ATE27455T1 - Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung. - Google Patents

Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.

Info

Publication number
ATE27455T1
ATE27455T1 AT83200388T AT83200388T ATE27455T1 AT E27455 T1 ATE27455 T1 AT E27455T1 AT 83200388 T AT83200388 T AT 83200388T AT 83200388 T AT83200388 T AT 83200388T AT E27455 T1 ATE27455 T1 AT E27455T1
Authority
AT
Austria
Prior art keywords
group
heterocyclic
processes
carbon atoms
linear
Prior art date
Application number
AT83200388T
Other languages
English (en)
Inventor
Giuseppe Bietti
Enzo Cereda
Arturo Donetti
Soldato Piero Del
Antonio Giachetti
Rosamaria Micheletti
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Application granted granted Critical
Publication of ATE27455T1 publication Critical patent/ATE27455T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C07D271/071,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/48Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/535Organo-phosphoranes
    • C07F9/5355Phosphoranes containing the structure P=N-
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5463Compounds of the type "quasi-phosphonium", e.g. (C)a-P-(Y)b wherein a+b=4, b>=1 and Y=heteroatom, generally N or O

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cosmetics (AREA)
AT83200388T 1982-03-24 1983-03-22 Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung. ATE27455T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT20356/82A IT1200371B (it) 1982-03-24 1982-03-24 Guanidino eterociclifenilamidine,processi per la loro preparazione e loro impiego farmaceutico
EP83200388A EP0089730B1 (de) 1982-03-24 1983-03-22 Heterocyclische Guanidino-Phenylamidine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung

Publications (1)

Publication Number Publication Date
ATE27455T1 true ATE27455T1 (de) 1987-06-15

Family

ID=11165991

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83200388T ATE27455T1 (de) 1982-03-24 1983-03-22 Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.

Country Status (24)

Country Link
US (2) US4548944A (de)
EP (1) EP0089730B1 (de)
JP (1) JPS58185574A (de)
KR (1) KR840004089A (de)
AT (1) ATE27455T1 (de)
AU (1) AU562246B2 (de)
CA (1) CA1190546A (de)
DD (1) DD232704A5 (de)
DE (2) DE89730T1 (de)
DK (1) DK63183A (de)
ES (3) ES8404982A1 (de)
FI (1) FI78476C (de)
GB (1) GB2116975B (de)
GR (1) GR77435B (de)
HU (1) HU187877B (de)
IL (1) IL68204A (de)
IT (1) IT1200371B (de)
NO (1) NO159269C (de)
NZ (1) NZ203663A (de)
PL (2) PL138921B1 (de)
PT (1) PT76432B (de)
SU (2) SU1151208A3 (de)
YU (2) YU43160B (de)
ZA (1) ZA832016B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1210914B (it) * 1982-07-29 1989-09-29 Angeli Inst Spa Eterociclilfenilsolfonil e fosfonilamidine sostituite, procedimento per la loro preparazione e loro uso farmaceutico.
GB9125970D0 (en) * 1991-12-06 1992-02-05 Fujisawa Pharmaceutical Co New compounds
GB9211163D0 (en) * 1992-05-26 1992-07-08 Fujisawa Pharmaceutical Co New oxazole derivatives
US6787490B2 (en) * 2001-12-26 2004-09-07 Kimberly-Clark Worldwide, Inc. Glove donning delivery system
KR100969686B1 (ko) 2006-08-07 2010-07-14 한국과학기술연구원 신규한 티아졸계 화합물 및 이를 함유하는 t-형 칼슘 채널저해제
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54132566A (en) * 1978-01-18 1979-10-15 Ici Ltd Guanidine derivative*its manufacture and secretion controlling pharmaceutical composition containing it
EP0014057B1 (de) * 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
IT1209431B (it) * 1980-11-28 1989-07-16 Angeli Inst Spa Imidazolilfenil amidine, processi per la loro preparazione e loro impiego farmaceutico, ed intermedi di preparazione.

Also Published As

Publication number Publication date
FI78476B (fi) 1989-04-28
NO831027L (no) 1983-09-26
FI78476C (fi) 1989-08-10
YU43418B (en) 1989-06-30
DE89730T1 (de) 1984-02-02
GB2116975B (en) 1985-08-14
ES520867A0 (es) 1984-05-16
NO159269B (no) 1988-09-05
US4548944A (en) 1985-10-22
ES520868A0 (es) 1984-05-16
YU68983A (en) 1986-06-30
JPS58185574A (ja) 1983-10-29
YU152185A (en) 1986-06-30
FI830940L (fi) 1983-09-25
PL138921B1 (en) 1986-11-29
IL68204A (en) 1987-02-27
FI830940A0 (fi) 1983-03-22
GB2116975A (en) 1983-10-05
PT76432A (en) 1983-04-01
HU187877B (en) 1986-02-28
ES520869A0 (es) 1984-05-16
SU1151208A3 (ru) 1985-04-15
ES8404982A1 (es) 1984-05-16
DK63183A (da) 1983-09-25
ES8404980A1 (es) 1984-05-16
EP0089730B1 (de) 1987-05-27
CA1190546A (en) 1985-07-16
US4645841A (en) 1987-02-24
ZA832016B (en) 1984-11-28
SU1251804A3 (ru) 1986-08-15
PT76432B (en) 1986-02-06
IT1200371B (it) 1989-01-18
PL241145A1 (en) 1984-07-30
AU1273283A (en) 1983-09-29
EP0089730A3 (en) 1984-09-12
KR840004089A (ko) 1984-10-08
PL139031B1 (en) 1986-11-29
NO159269C (no) 1988-12-14
DD232704A5 (de) 1986-02-05
YU43160B (en) 1989-04-30
DE3371784D1 (en) 1987-07-02
EP0089730A2 (de) 1983-09-28
GB8307957D0 (en) 1983-04-27
ES8404981A1 (es) 1984-05-16
NZ203663A (en) 1986-01-24
PL246384A1 (en) 1984-11-19
DK63183D0 (da) 1983-02-14
GR77435B (de) 1983-09-14
AU562246B2 (en) 1987-06-04
IT8220356A0 (it) 1982-03-24

Similar Documents

Publication Publication Date Title
ATE27455T1 (de) Heterocyclische guanidino-phenylamidine, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
EP0094727A3 (de) Substituierte heterocyclische Phenylformamidine, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
DE3479212D1 (en) New amidine derivatives of 2-substituted 4-phenilimidazole
ATE22683T1 (de) Substituiertes heterocyclylphenylsulphonyl und phosphonylamidine, verfahren zu deren herstellung und deren pharmazeutische anwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee